An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents (NAC MJ Pilot)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00542750
Recruitment Status :
First Posted : October 11, 2007
Results First Posted : May 23, 2018
Last Update Posted : May 23, 2018
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)
American Academy of Child Adolescent Psychiatry.
Information provided by (Responsible Party):
Kevin Gray, MD, Medical University of South Carolina
24 participants were recruited over 9 months in 2008-2009.
After informed consent, an assessment/screening visit was used to determine if prospective participants met criteria for inclusion. Briefly, participants were required to be regular cannabis users meeting current criteria for dependence. Participants with unstable psychiatric or medical issues were excluded.
All participants received N-Acetylc...
All participants received N-Acetylcysteine 1200 mg twice daily during four weeks of participation. Tolerability, marijuana use, and reactivity to marijuana cues were investigated.